Disciplined Value SeriesMDVZX
Type
Mutual fund
Peer group
US equity: large companies
Net assets
$146.2M
Expense ratio
0.40%
1-year return
+32.6%
3 years, a year
+15.3%
5 years, a year
+9.7%
Holdings
117
What it aims to do.
To provide competitive returns consistent with the broad equity market while also providing a level of capital protection during market downturns.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| MRK Merck & Company Inc | 3.58% |
| UNH Unitedhealth Group Inc | 3.44% |
| C Citigroup Inc | 3.35% |
| QCOM Qualcomm Inc | 3.19% |
| XOM Exxon Mobil Corp | 3.06% |
| GILD Gilead Sciences Inc | 2.58% |
| COP Conocophillips | 2.54% |
| WFC Wells Fargo & Company | 2.51% |
| BMY Bristol-Myers Squibb Company | 2.18% |
| PGR Progressive Corp (The) | 2.00% |
More on MDVZX.
- MDVZX overview
- MDVZX holdings
- MDVZX risk
- MDVZX costs
- MDVZX money in and out
- MDVZX share classes
- Compare MDVZX with other funds
Returns after fees, from the fund's SEC filings up to Apr 2026. Past returns are not a promise. Not financial advice.